Chen Schor - May 5, 2021 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
President & CEO, Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Stock symbol
ACET
Transactions as of
May 5, 2021
Transactions value $
-$234,222
Form type
4
Date filed
5/7/2021, 04:02 PM
Next filing
May 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale -$61.5K -4.43K -4.22% $13.90 100K May 5, 2021 See Footnote F1, F2, F3
transaction ACET Common Stock Sale -$45K -3.06K -3.05% $14.70 97.3K May 5, 2021 See Footnote F1, F3, F4
transaction ACET Common Stock Sale -$73.8K -5.31K -4.22% $13.90 120K May 5, 2021 See Footnote F1, F2, F5
transaction ACET Common Stock Sale -$54K -3.67K -3.05% $14.70 117K May 5, 2021 See Footnote F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.51 to $14.48, inclusive.
F3 Represents shares held directly by an irrevocable family trust having an independent trustee.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.53 to $15.04, inclusive.
F5 Represents shares held directly by an irrevocable family trust having an independent trustee.